Your session is about to expire
← Back to Search
Home Ultrasound users for Perinatal Care
Study Summary
This trial is designed to study the safety and feasibility of a new medical device when used by pregnant individuals.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What is the maximum capacity for enrollment in this clinical trial?
"This clinical trial necessitates the involvement of 180 eligible patients. Those interested in taking part can visit either Center for Fetal Medicine and Women's Ultrasound located in Los Angeles, California or one of the Mount Sinai Hospital System locations situated in New york, New York."
What is the operative aim of this medical research?
"The primary goal of the clinical trial, which will take place between weeks 14 and 38 in gestation, is to contrast data derived from a device with factual evidence regarding fetal cardiac activity. Secondary outcomes evaluate if the device can recognize fetal presentation compared to physical scans, indicates breathing through comparison to traditional ultrasound readings, and ascertains movement when juxtaposed against real-time observations."
Are there vacancies open to individuals for participation in this examination?
"Indeed, the information stored on clinicaltrials.gov suggests that this research project is still open for recruitment. It was originally posted in April 14th 2022 and updated most recently in March 27th 2023 with a target of 180 participants at 4 clinics."
How many settings are hosting this clinical investigation?
"Participants for this trial can be recruited at Center for Fetal Medicine and Women's Ultrasound in Los Angeles, Mount Sinai Hospital System in New york, University of Florida College of Medicine in Gainesville as well as an additional four sites."
Share this study with friends
Copy Link
Messenger